{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T11:54:24Z","timestamp":1767182064552,"version":"3.40.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012295","name":"NIHR Newcastle Biomedical Research Centre","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012295","id-type":"DOI","asserted-by":"crossref"}]},{"name":"University of Newcastle Priority Research Centre for Drug Development"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s10822-021-00387-5","type":"journal-article","created":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T08:04:42Z","timestamp":1620115482000},"page":"613-628","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Development and interpretation of a QSAR model for in vitro breast cancer (MCF-7) cytotoxicity of 2-phenylacrylonitriles"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7516-7249","authenticated-orcid":false,"given":"David T.","family":"Stanton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9560-301X","authenticated-orcid":false,"given":"Jennifer R.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7125-863X","authenticated-orcid":false,"given":"Adam","family":"McCluskey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4100-1467","authenticated-orcid":false,"given":"Stefan","family":"Paula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,4]]},"reference":[{"key":"387_CR1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4137\/BCBCR.S39385","volume":"10","author":"M Krohe","year":"2016","unstructured":"Krohe M, Hao Y, Lamourex RE, Galipeau N, Globe D, Foley C, Mazar I, Solomon J, Shields AL (2016) Patient-reported outcomes in metastatic breast cancer: a review of industry\u2014sponsored clinical trials. Breast Cancer Basic Clin Res 10:93\u2013102","journal-title":"Breast Cancer Basic Clin Res"},{"key":"387_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.soc.2019.08.004","volume":"29","author":"I Greenwalt","year":"2019","unstructured":"Greenwalt I, Zaza N, Das S, Li BD (2019) Precision medicine and targeted therapies in breast cancer. Surg Oncol Clin N Am 29:51\u201362","journal-title":"Surg Oncol Clin N Am"},{"key":"387_CR3","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.clbc.2016.05.012","volume":"16","author":"Y Tang","year":"2016","unstructured":"Tang Y, Wang Y, Kiani MF, Wang B (2016) Classification, treatment strategy, and associated drug resistance in breast cancer. Clin Breast Cancer 16:335\u2013343","journal-title":"Clin Breast Cancer"},{"key":"387_CR4","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1093\/nop\/npz003","volume":"6","author":"J Fares","year":"2019","unstructured":"Fares J, Kanojia D, Cordero A, Rashidi A, Miska J, Schwartz CW, Savchuk S, Ahmed AU, Balyasnikova IV, Cristofanilli M, Gradishar WJ, Lesniak MS (2019) Current state of clinical trials in breast cancer brain metastases. Neuro Oncol Pract 6:392\u2013401","journal-title":"Neuro Oncol Pract"},{"key":"387_CR5","doi-asserted-by":"publisher","first-page":"957","DOI":"10.3390\/cells8090957","volume":"8","author":"M Nedeljkovi\u0107","year":"2019","unstructured":"Nedeljkovi\u0107 M, Damjanovi\u0107 A (2019) Mechanisms of chemotherapy resistance in triple-negative breast cancer: how we can rise to the challenge. Cells 8:957","journal-title":"Cells"},{"key":"387_CR6","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1002\/cmdc.201800256","volume":"14","author":"JR Baker","year":"2018","unstructured":"Baker JR, Gilbert J, Paula S, Zhu X, Sakoff JA, McCluskey A (2018) Dichlorophenylacrylonitriles as AhR ligands that display selective breast cancer cytotoxicity in vitro. ChemMedChem 14:1447\u20131458","journal-title":"ChemMedChem"},{"key":"387_CR7","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.4236\/jct.2013.47137","volume":"4","author":"JB Powell","year":"2014","unstructured":"Powell JB, Goode GD, Eltom SE (2014) The aryl hydrocarbon receptor: a target for breast cancer therapy. J Cancer Ther 4:1177\u20131186","journal-title":"J Cancer Ther"},{"key":"387_CR8","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/med.21645","volume":"40","author":"JR Baker","year":"2020","unstructured":"Baker JR, Sakoff JA, McCluskey A (2020) The arylhydrocarbon receptor (AhR) as a breast cancer drug target. Med Res Rev 40:972\u20131001","journal-title":"Med Res Rev"},{"key":"387_CR9","doi-asserted-by":"publisher","first-page":"11415","DOI":"10.1016\/S0021-9258(19)70307-X","volume":"255","author":"AB Okey","year":"1980","unstructured":"Okey AB, Bondy GP, Mason ME, Nebert DW, Forster-Gibson CJ, Muncan J, Dufresne MJ (1980) Temperature-dependent cytosol-to-nucleus translocation of the Ah receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in continuous cell culture lines. J Biol Chem 255:11415\u201311422","journal-title":"J Biol Chem"},{"key":"387_CR10","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1146\/annurev-immunol-032713-120245","volume":"32","author":"B Stockinger","year":"2014","unstructured":"Stockinger B, Di Meglio P, Gialitakis M, Duarte JH (2014) The aryl hydrocarbon receptor: multitasking in the immune system. Annu Rev Immunol 32:403\u2013432","journal-title":"Annu Rev Immunol"},{"key":"387_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev.pharmtox.43.100901.135828","volume":"43","author":"MS Denison","year":"2003","unstructured":"Denison MS, Nagy SR (2003) Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol 43:309\u2013334","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"387_CR12","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/17425255.2019.1569627","volume":"15","author":"P Tarnow","year":"2019","unstructured":"Tarnow P, Tralau T, Luch A (2019) Chemical activation of estrogen and arylhydrocarbon receptor signalling pathways and their interaction in toxicology and metabolism. Expert Opin Drug Metab Toxicol 15:219\u2013229","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"387_CR13","first-page":"343","volume":"38","author":"WA Turski","year":"2020","unstructured":"Turski WA, Wnorowski A, Turski AN, Turski CA, Turski L (2020) AhR and IDO1 in pathogenesis of Covid-19 and the \u201cSystemic AhR Activation Syndrome:\u201d a translational review and therapeutic perspectives. Restor Neurol Neurosci 38:343\u2013354","journal-title":"Restor Neurol Neurosci"},{"key":"387_CR14","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1002\/anie.201912392","volume":"59","author":"IVL Wilkinson","year":"2020","unstructured":"Wilkinson IVL, Perkins KJ, Dugdale H, Moir L, Vuorinen A, Chatzopoulou M, Squire SE, Monecke S, Lomov A, Geese M, Charles PD, Burch P, Tinsley JM, Wynne GM, Davies SG, Wilson FX, Rastinejad F, Mohammed S, Davies KE, Russell AJ (2020) Chemical proteomics and phenotypic profiling identifies the aryl hydrocarbon receptor as a molecular target of utrophin modulator ezutromid. Angew Chem Int Ed 59:2420\u20132428","journal-title":"Angew Chem Int Ed"},{"key":"387_CR15","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1124\/mol.117.109827","volume":"93","author":"J Gilbert","year":"2018","unstructured":"Gilbert J, De Iuliis GN, Tarleton M, McCluskey A, Sakoff JA (2018) (Z)-2-(3,4-Dichlorophenyl)-3-(1H-Pyrrol-2-yl)acrylonitrile exhibits selective antitumour activity in breast cancer cell lines via the Aryl hydrocarbon Receptor pathway. Mol Pharmacol 93:168\u2013177","journal-title":"Mol Pharmacol"},{"key":"387_CR16","doi-asserted-by":"publisher","first-page":"13978","DOI":"10.1038\/s41598-020-70597-8","volume":"10","author":"J Gilbert","year":"2020","unstructured":"Gilbert J, De Iuliis GN, McCluskey A, Sakoff JA (2020) A novel naphthalimide that selectively targets breast cancer via the arylhydrocarbon receptor pathway. Sci Rep 10:13978","journal-title":"Sci Rep"},{"key":"387_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202000721","author":"JR Baker","year":"2021","unstructured":"Baker JR, Pollard BL, Lin AJS, Gilbert S, Paula S, Zhu X, Sakoff JA, McCluskey A (2021) Modelling and phenotypic screening of NAP-6 and 10-Cl-BBQ AhR ligands displaying selective breast cancer cytotoxicity in vitro. ChemMedChem (In press). https:\/\/doi.org\/10.1002\/cmdc.202000721","journal-title":"ChemMedChem (In press)"},{"key":"387_CR18","volume-title":"Molecular docking and molecular dynamics","author":"S Paula","year":"2019","unstructured":"Paula S, Baker JR, Zhu X, McCluskey A (2019) Binding of chlorinated phenylacrylonitriles to the aryl hydrocarbon receptor: computational docking and molecular dynamics simulations. In: Stefaniu A (ed) Molecular docking and molecular dynamics. Rijeka, Intech"},{"key":"387_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1039\/C0MD00147C","volume":"2","author":"M Tarleton","year":"2011","unstructured":"Tarleton M, Gilbert J, Robertson MJ, McCluskey A, Sakoff JA (2011) Library synthesis and cytotoxicity of a family of 2-phenylacrylonitriles and discovery of an estrogen dependent cancer lead compound. Med Chem Commun 2:31\u201337","journal-title":"Med Chem Commun"},{"key":"387_CR20","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","volume":"82","author":"P Skehan","year":"1990","unstructured":"Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82:1107\u20131112","journal-title":"J Natl Cancer Inst"},{"key":"387_CR21","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/cmdc.201900643","volume":"15","author":"JR Baker","year":"2020","unstructured":"Baker JR, Russell CC, Gilbert J, Sakoff JA, McCluskey A (2020) Amino alcohol acrylonitriles as activators of the aryl hydrocarbon receptor pathway, an unexpected MTT phenotypic screening outcome. ChemMedChem 15:490\u2013505","journal-title":"ChemMedChem"},{"key":"387_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejmech.2012.09.019","volume":"57","author":"M Tarleton","year":"2012","unstructured":"Tarleton M, Gilbert J, Sakoff JA, McCluskey A (2012) Cytotoxic 2-phenylacrylnitriles, the importance of the cyanide moiety and discovery of potent broad spectrum cytotoxic agents. Eur J Med Chem 57:65\u201373","journal-title":"Eur J Med Chem"},{"key":"387_CR23","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.bmc.2012.10.003","volume":"21","author":"M Tarleton","year":"2013","unstructured":"Tarleton M, Dyson L, Gilbert J, Sakoff JA, McCluskey A (2013) Focused library development of 2-phenylacrylamides as broad spectrum cytotoxic agents. Bioorgan Med Chem 21:333\u2013347","journal-title":"Bioorgan Med Chem"},{"key":"387_CR24","doi-asserted-by":"publisher","DOI":"10.1039\/c3ra47418f","author":"A Al Otaibi","year":"2014","unstructured":"Al Otaibi A, Gordon CP, Gilbert J, Sakoff JA, McCluskey A (2014) The influence of ionic liquids on the Knoevenagel condensation of 1H-pyrrole-2-carbaldehyde with phenyl acetonitriles-cytotoxic 3-substituted-(1H-pyrrol-2-yl)acrylonitriles. RSC Adv. https:\/\/doi.org\/10.1039\/c3ra47418f","journal-title":"RSC Adv"},{"key":"387_CR25","volume-title":"Molecular connectivity in structure-activity analysis","author":"LB Kier","year":"1986","unstructured":"Kier LB, Hall LH (1986) Molecular connectivity in structure-activity analysis. Research Studies Press, Letchworth"},{"key":"387_CR26","volume-title":"Molecular structure description. The electrotopological state","author":"LB Kier","year":"1999","unstructured":"Kier LB, Hall LH (1999) Molecular structure description. The electrotopological state. Academic Press, San Diego"},{"key":"387_CR27","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10822-008-9204-9","volume":"22","author":"DT Stanton","year":"2008","unstructured":"Stanton DT (2008) On the importance of topological descriptors in understanding structure-property relationships. J Comput Aided Mol Des 22:441\u2013460","journal-title":"J Comput Aided Mol Des"},{"key":"387_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0922-3487(06)80006-7","volume":"15","author":"JM Sutter","year":"1995","unstructured":"Sutter JM, Jurs PC (1995) Selection of molecular descriptors for quantitative structure-activity relationships. Data Handl Sci Tech 15:111\u2013132","journal-title":"Data Handl Sci Tech"},{"key":"387_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/B978-012213810-2\/50003-7","volume-title":"Genetic algorithms in molecular modeling","author":"BT Luke","year":"1996","unstructured":"Luke BT (1996). In: Devillers J (ed) Genetic algorithms in molecular modeling. Academic Press, New York, pp 35\u201366"},{"key":"387_CR30","volume-title":"Applied linear statistical models","author":"MH Kutner","year":"2005","unstructured":"Kutner MH, Nachtsheim CJ, Neter J, Li W (2005) Applied linear statistical models, 5th edn. McGraw-Hill Irwin, New York","edition":"5"},{"key":"387_CR31","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1021\/ci800253u","volume":"48","author":"G Suhuurmann","year":"2008","unstructured":"Suhuurmann G, Ebert R, Chen J, Wang B, Kuhne R (2008) External validation and prediction employing the predictive squared correlation coefficient\u2013Test set activity mean vs training set activity mean. J Chem Inf Model 48:2140\u20132145","journal-title":"J Chem Inf Model"},{"key":"387_CR32","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2174\/157340912800492357","volume":"8","author":"DT Stanton","year":"2012","unstructured":"Stanton DT (2012) QSAR and QSPR model interpretation using partial least squares (PLS) analysis. Curr Comput Aided Drug Des 8:107\u2013127","journal-title":"Curr Comput Aided Drug Des"},{"key":"387_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/0471725382","volume-title":"Robust regression & outlier detection","author":"PJ Rousseeuw","year":"1987","unstructured":"Rousseeuw PJ, Leroy AM (1987) Robust regression & outlier detection. Wiley, New York"},{"key":"387_CR34","first-page":"309","volume-title":"Statistical validation of QSAR results","author":"S Wold","year":"1995","unstructured":"Wold S, Eriksson L (1995). In: van de Waterbeemd H (ed) Statistical validation of QSAR results. VCH, New York, pp 309\u2013318"},{"key":"387_CR35","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1021\/ci0340658","volume":"43","author":"DT Stanton","year":"2003","unstructured":"Stanton DT (2003) On the physical interpretation of QSAR models. J Chem Inf Comput Sci 43:1423\u20131433","journal-title":"J Chem Inf Comput Sci"},{"key":"387_CR36","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1080\/00401706.1978.10489693","volume":"20","author":"S Wold","year":"1978","unstructured":"Wold S (1978) Cross-validatory estimation of the number of components in factor and principal components models. Technometrics 20:397\u2013405","journal-title":"Technometrics"},{"key":"387_CR37","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1021\/jm00196a017","volume":"22","author":"JG Topliss","year":"1979","unstructured":"Topliss JG, Edwards RP (1979) Chance factors in studies of quantitative structure-activity relationships. J Med Chem 22:1238\u20131244","journal-title":"J Med Chem"},{"key":"387_CR38","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1021\/ci8002073","volume":"48","author":"AR Katritzky","year":"2008","unstructured":"Katritzky AR, Dobchev DA, Slavov S, Karelson M (2008) Legitimate utilization of large descriptor pools for QSAR\/QSPR models. J Chem Inf Model 48:2207\u20132213","journal-title":"J Chem Inf Model"},{"key":"387_CR39","first-page":"341","volume-title":"Applied multivariate statistical analysis","author":"RA Johnson","year":"1988","unstructured":"Johnson RA, Wichern DW (1988) Applied multivariate statistical analysis, 2nd edn. Prentice-Hall, Englewood Cliffs, New Jersey, p 341","edition":"2"},{"key":"387_CR40","first-page":"319","volume-title":"An introduction to statistical methods and data analysis","author":"L Ott","year":"1988","unstructured":"Ott L (1988) An introduction to statistical methods and data analysis, 3rd edn. PWS-Kent, Boston, pp 319\u2013323","edition":"3"},{"key":"387_CR41","doi-asserted-by":"publisher","first-page":"13262","DOI":"10.1039\/C4CP01280A","volume":"16","author":"N Sagawa","year":"2014","unstructured":"Sagawa N, Shikata T (2014) Are all polar molecules hydrophilic? Hydration numbers of nitro compounds and nitriles in aqueous solution. Phys Chem Chem Phys 16:13262\u201313270","journal-title":"Phys Chem Chem Phys"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-021-00387-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-021-00387-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-021-00387-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:44:43Z","timestamp":1744152283000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-021-00387-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["387"],"URL":"https:\/\/doi.org\/10.1007\/s10822-021-00387-5","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"type":"print","value":"0920-654X"},{"type":"electronic","value":"1573-4951"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"9 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}